These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 18192894

  • 1. Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms.
    Fanta S, Niemi M, Jönsson S, Karlsson MO, Holmberg C, Neuvonen PJ, Hoppu K, Backman JT.
    Pharmacogenet Genomics; 2008 Feb; 18(2):77-90. PubMed ID: 18192894
    [Abstract] [Full Text] [Related]

  • 2. A drug transporter for all ages? ABCB1 and the developmental pharmacogenetics of cyclosporine.
    Hesselink DA, van Schaik RH, Nauta J, van Gelder T.
    Pharmacogenomics; 2008 Jun; 9(6):783-9. PubMed ID: 18518855
    [Abstract] [Full Text] [Related]

  • 3. Haplotypic structure of ABCB1/MDR1 gene modifies the risk of the acute allograft rejection in renal transplant recipients.
    Bandur S, Petrasek J, Hribova P, Novotna E, Brabcova I, Viklicky O.
    Transplantation; 2008 Nov 15; 86(9):1206-13. PubMed ID: 19005401
    [Abstract] [Full Text] [Related]

  • 4. Effect of ABCB1 (MDR1) haplotypes derived from G2677T/C3435T on the pharmacokinetics of amlodipine in healthy subjects.
    Kim KA, Park PW, Park JY.
    Br J Clin Pharmacol; 2007 Jan 15; 63(1):53-8. PubMed ID: 16869811
    [Abstract] [Full Text] [Related]

  • 5. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation.
    Hauser IA, Schaeffeler E, Gauer S, Scheuermann EH, Wegner B, Gossmann J, Ackermann H, Seidl C, Hocher B, Zanger UM, Geiger H, Eichelbaum M, Schwab M.
    J Am Soc Nephrol; 2005 May 15; 16(5):1501-11. PubMed ID: 15772250
    [Abstract] [Full Text] [Related]

  • 6. Long-term changes in cyclosporine pharmacokinetics after renal transplantation in children: evidence for saturable presystemic metabolism and effect of NR1I2 polymorphism.
    Fanta S, Jönsson S, Karlsson MO, Niemi M, Holmberg C, Hoppu K, Backman JT.
    J Clin Pharmacol; 2010 May 15; 50(5):581-97. PubMed ID: 20107201
    [Abstract] [Full Text] [Related]

  • 7. Genetic polymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans.
    Park HJ, Shinn HK, Ryu SH, Lee HS, Park CS, Kang JH.
    Clin Pharmacol Ther; 2007 Apr 15; 81(4):539-46. PubMed ID: 17192767
    [Abstract] [Full Text] [Related]

  • 8. Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients.
    Quteineh L, Verstuyft C, Furlan V, Durrbach A, Letierce A, Ferlicot S, Taburet AM, Charpentier B, Becquemont L.
    Basic Clin Pharmacol Toxicol; 2008 Dec 15; 103(6):546-52. PubMed ID: 19067682
    [Abstract] [Full Text] [Related]

  • 9. Population pharmacokinetics and pharmacogenetics of imatinib in children and adults.
    Petain A, Kattygnarath D, Azard J, Chatelut E, Delbaldo C, Geoerger B, Barrois M, Séronie-Vivien S, LeCesne A, Vassal G, Innovative Therapies with Children with Cancer European consortium.
    Clin Cancer Res; 2008 Nov 01; 14(21):7102-9. PubMed ID: 18981009
    [Abstract] [Full Text] [Related]

  • 10. Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5 *3/*3 non-expressors.
    Wang J, Zeevi A, McCurry K, Schuetz E, Zheng H, Iacono A, McDade K, Zaldonis D, Webber S, Watanabe RM, Burckart GJ.
    Transpl Immunol; 2006 Jan 01; 15(3):235-40. PubMed ID: 16431292
    [Abstract] [Full Text] [Related]

  • 11. Common ATP-binding cassette B1 variants are associated with increased digoxin serum concentration.
    Aarnoudse AJ, Dieleman JP, Visser LE, Arp PP, van der Heiden IP, van Schaik RH, Molokhia M, Hofman A, Uitterlinden AG, Stricker BH.
    Pharmacogenet Genomics; 2008 Apr 01; 18(4):299-305. PubMed ID: 18334914
    [Abstract] [Full Text] [Related]

  • 12. Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients.
    Crettol S, Venetz JP, Fontana M, Aubert JD, Ansermot N, Fathi M, Pascual M, Eap CB.
    Pharmacogenet Genomics; 2008 Apr 01; 18(4):307-15. PubMed ID: 18334915
    [Abstract] [Full Text] [Related]

  • 13. Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients.
    Vaclavikova R, Nordgard SH, Alnaes GI, Hubackova M, Kubala E, Kodet R, Mrhalova M, Novotny J, Gut I, Kristensen VN, Soucek P.
    Pharmacogenet Genomics; 2008 Mar 01; 18(3):263-73. PubMed ID: 18300948
    [Abstract] [Full Text] [Related]

  • 14. Determination of ABCB1 polymorphisms and haplotypes frequencies in a French population.
    Jeannesson E, Albertini L, Siest G, Gomes AM, Ribeiro V, Aslanidis C, Schmitz G, Visvikis-Siest S.
    Fundam Clin Pharmacol; 2007 Aug 01; 21(4):411-8. PubMed ID: 17635180
    [Abstract] [Full Text] [Related]

  • 15. ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals.
    Coller JK, Barratt DT, Dahlen K, Loennechen MH, Somogyi AA.
    Clin Pharmacol Ther; 2006 Dec 01; 80(6):682-90. PubMed ID: 17178268
    [Abstract] [Full Text] [Related]

  • 16. Multi-drug resistance gene-1 (MDR-1) haplotypes and the CYP3A5*1 genotype have no influence on ciclosporin dose requirements as assessed by C0 or C2 measurements.
    Fredericks S, Jorga A, MacPhee IA, Reboux S, Shiferaw E, Moreton M, Carter ND, Holt DW, Johnston A.
    Clin Transplant; 2007 Dec 01; 21(2):252-7. PubMed ID: 17425754
    [Abstract] [Full Text] [Related]

  • 17. Pharmacogenomic associations in ABCB1 and CYP3A5 with acute kidney injury and chronic kidney disease after myeloablative hematopoietic cell transplantation.
    Woodahl EL, Hingorani SR, Wang J, Guthrie KA, McDonald GB, Batchelder A, Li M, Schoch HG, McCune JS.
    Pharmacogenomics J; 2008 Aug 01; 8(4):248-55. PubMed ID: 17700595
    [Abstract] [Full Text] [Related]

  • 18. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
    Fukudo M, Yano I, Yoshimura A, Masuda S, Uesugi M, Hosohata K, Katsura T, Ogura Y, Oike F, Takada Y, Uemoto S, Inui K.
    Pharmacogenet Genomics; 2008 May 01; 18(5):413-23. PubMed ID: 18408564
    [Abstract] [Full Text] [Related]

  • 19. Associations between common variants in the MDR1 (ABCB1) gene and ulcerative colitis among North Indians.
    Juyal G, Midha V, Amre D, Sood A, Seidman E, Thelma BK.
    Pharmacogenet Genomics; 2009 Jan 01; 19(1):77-85. PubMed ID: 19005421
    [Abstract] [Full Text] [Related]

  • 20. Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis.
    Beringer PM, Kriengkauykiat J, Zhang X, Hidayat L, Liu S, Louie S, Synold T, Burckart GJ, Rao PA, Shapiro B, Gill M.
    Pharmacotherapy; 2008 Jul 01; 28(7):883-94. PubMed ID: 18576903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.